Global Formulation Development Outsourcing Market Size study, By Service (Preformulation, Formulation Development), By Formulation (Oral, Injectable, Topical, Others), By Application (Oncology, Neurology, Infectious Disease, Cardiovascular, Others), and R

Global Formulation Development Outsourcing Market Size study, By Service (Preformulation, Formulation Development), By Formulation (Oral, Injectable, Topical, Others), By Application (Oncology, Neurology, Infectious Disease, Cardiovascular, Others), and Regional Forecasts 2022-2028Global Formulation Development Outsourcing Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Formulation development is a method of determining the lifecycle, patentability, and accomplishment of the pharmaceutical product. This process includes pre-formulation such as excipient screening to stabilize, analytical assay development & characterization. Formulation development outsourcing provides a wide range of benefits, such as accessing expertise, compressing timelines, and giving extra insurance against product failure. The thriving growth of the pharmaceutical & biotechnology sector, increasing cost-effectiveness of formulation outsourcing services, and the growing trend of patent protection expiration of major drugs are the primary factors impelling the global market demand. For instance, according to the Indian Brand Equity Foundation (IBEF), in India, the pharmaceutical market was estimated to be worth around USD 42 billion in 2021. Also, it is anticipated that the market progressively grows and reach nearly 130 billion by 2030. Accordingly, the flourishing development of the pharmaceutical sector is excelling the growth of the market around the world. However, structural changes in the pharmaceutical industry and insufficient funding to perform the drug development process through formulation development impede the growth of the market over the forecast period of 2022-2028. Also, the rising R&D spending and substantial development of the emerging markets are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Formulation Development Outsourcing Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the rapid adoption of novel technologies, and the presence of various prominent market players. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the growing investments in research and development activities, and the growth of various emerging markets such as South Korea, India, Japan, and China would create lucrative growth prospects for the Formulation Development Outsourcing Market across the Asia-Pacific region.

Major market players included in this report are:

SGS S.A.
Intertek Group plc
Recipharm
Lonza
Charles River Laboratories International, Inc.
Eurofins Scientific SE
Element
Labcorp
Thermo Fisher Scientific, Inc. (Patheon)
Catalent Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Service:
Preformulation
Formulation Development
By Formulation:
Oral
Injectable
Topical
Others
By Application:
Oncology
Neurology
Infectious Disease
Cardiovascular
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Formulation Development Outsourcing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


Companies Mentioned

SGS S.A.
Intertek Group plc
Recipharm
Lonza
Charles River Laboratories International, Inc.
Eurofins Scientific SE
Element
Labcorp
Thermo Fisher Scientific, Inc. (Patheon)
Catalent Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.